Official Title: Celecoxib Pain Management Following Superficial Parotidectomy Opioid Sparing Protocol
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to find out whether pain can be managed after an operation with celecoxib instead of oxycodone The main question it aims to answer is if use of celecoxib plus Tylenol reduces the need for oxycodone
Researchers will compare the combination of celecoxib and Tylenol to a placebo to find out whether celecoxib works to manage pain
Participants will
Take celecoxib or a placebo plus Tylenol with opioids as needed Keep a diary of their pain between visits Complete questionnaires
Detailed Description: Surgeons have a unique opportunity to reduce opioid prescriptions - and therefore potential opioid dependence morbidity and mortality - by altering prescribing patterns in the perioperative period This study aims to determine if celecoxib is a viable alternative for acute pain control in the postoperative setting for head and neck surgeries which could significantly reduce the amount of narcotic pain pills in circulation and can be extrapolated to other otolaryngologic procedures